Maidapeisi Medical

迈达佩思

Maidapeisi Medical

Biotech/Healthcare

Maidapeisi develops implantable and wearable neuromodulation therapies for gastrointestinal disorders, particularly functional gastrointestinal and metabolic diseases. Its founder is a laboratory director at Johns Hopkins and chaired the field’s first global industry conference.

Latest round: Series A Extension (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-07-01